000			01076nam a2200133Ia 4500
008			220615s9999||||xx |||||||||||||| ||und||
020			_a9783040000000
245		0	_aMonoclonal Antibody-Directed Therapy
546			_aEnglish[eng]
650			_atherapeutic antibody||stability||aggregation||manufacture challenges||formulation||antibodies||site-specific conjugation||bioconjugates||ADC||antibody-drug conjugates||payloads||linkers||nucleic acids||ADME||developability||glycosylation||post-translational modifications||pharmacokinetics||effector functions||antibody-dependent cell-mediated cytotoxicity||complement-dependent cytotoxicity||immunogenicity||pharmacodynamics||glycoengineering||type III secretion system||prophylaxis||antibacterials||antibiotics||HIV/AIDS||co-formulation||high concentration||analytical characterization||antibody (s)||T-cell engagers||bispecific antibodies||immunotherapy||oncology||antibody engineering||immunological synapse
700			_aKayser, Veysel||Datta-Mannan, Amita
856			_uhttps://mdpi.com/books/pdfview/book/4899
942			_cEB
999			_c15394 _d15394